Genethon & Hansa begin phase 2 trial of imlifidase as a pre-treatment to GNT-0003 in severe Crigler-Najjar syndrome: Lund, Sweden Wednesday, December 4, 2024, 18:00 Hrs [IST] Hans ...
The gene-editing technique known as CRISPR is promising to revolutionize medicine. Some researchers are trying to help make it available for people with very rare genetic disorders.